News

Pharmacies in Nipissing Providing COVID-19 Vaccinations

Locations across the province offering AstraZeneca vaccine to individuals aged 55+

NORTH BAY – MPP Fedeli is pleased to announce that the Ontario government is steadily increasing capacity in its COVID-19 vaccine rollout with the inclusion of over 325 additional pharmacies and more primary care settings across the province. The Nipissing area will be providing vaccines at 3 new locations.

Local locations include:

• Northern Shores Pharmacy (10 Maplewood Avenue – North Bay)
• Wal-Mart Pharmacy (1500 Fisher St, North Bay)
• Loblaw Pharmacy #4230 (12035 Highway #17, Sturgeon Falls)

All of these locations will be offering the AstraZeneca vaccine to individuals aged 55 and over that are interested in receiving the AstraZeneca vaccine, with some locations to begin offering the vaccine as early as Saturday, April 3, 2021.

Details on how to book your vaccine can be found on the following website:
https://covid-19.ontario.ca/vaccine-locations

Appointment details:

• Appointment only. Call or visit the pharmacy website to make an appointment

“We encourage everyone to sign up when it’s their turn,” said MPP Vic Fedeli. “Our government is ready to dramatically increase the number of vaccines we can administer once we receive a steady and reliable supply from the federal government.”

Today’s expansion brings the total number of pharmacies offering the vaccine to nearly 700 locations, it is expected that this number could reach approximately 1,500 by the end of April. Additional pharmacies and primary care settings will continue to join and increase access points for vaccine across the province.

The province also continues to work with primary care professionals to offer vaccinations in primary care settings and community locations, such as physician offices.

Quick Facts

• Find the list of pharmacies offering the AstraZeneca vaccine as the province prepares for Phase 2 of Ontario’s COVID-19 Vaccine Rollout.
• As of March 31, 2021, at 8:00 p.m., over 2,275,000 vaccine doses have been administered across the province, with over 81 per cent of Ontario residents aged 80 and over having received at least one dose. More than half of residents aged 75 to 79 have now received their first shot. Over 317,000 Ontarians are fully immunized, including 91 per cent of long-term care residents. Ontario is leading the country in the total number of vaccines administered and has fully immunized more individuals than all provinces and territories combined.
• Only COVID-19 vaccines that Health Canada determines to be safe and effective will be approved for use in Ontario. In alignment with updated NACI recommendations, Ontario will not use AstraZeneca vaccine for individuals under 55, while data is being reviewed by Health Canada.
• Vaccinations with the AstraZeneca/COVISHIELD vaccine at pharmacies require an appointment to be made in advance. As of April 3, eligible adults aged 55 and over (if 55 or older as of the day of vaccination or, if will be 55 or older in 2021) who are interested in booking an appointment, can visit ontario.ca/pharmacycovidvaccine to find a participating pharmacy and can contact the pharmacy to make an appointment.
• Vaccinations with the AstraZeneca/COVISHIELD vaccine at primary care settings will expand according to available supply. Appointments are not being taken by request. Do not call your primary care providers to book an appointment – as of April 3, participating primary care providers in select areas will be reaching out to eligible Ontarians aged 55 or older.
• Participation and performance in the 2020-2021 Universal Influenza Immunization Program (UIIP), as well as capacity and readiness for vaccinations, have been part of the criteria of selection to bring onboard the pharmacies. The province is also ensuring that all pharmacies, chain and independent are participating. Site selection also included input from local public health units, the Ontario Pharmacists Association (OPA) and Neighbourhood Pharmacy Association of Canada (NPAC). Regions with high COVID-19 rates were prioritized.
• In March, Ontario received 1,454,310 doses of the Pfizer-BioNTech COVID-19 vaccine, the first shipment of 323,200 doses of the Moderna vaccine (225,600 doses delayed until April) and 194,500 doses of the AstraZeneca/COVISHIELD vaccine. An additional 583,400 doses of the AstraZeneca/COVISHIELD vaccine was received on April 1. In April, the province is expecting to receive 1,584,180 doses of the Pfizer-BioNTech vaccine and 751,500 doses of the Moderna vaccine.